Correlation Between Pfizer and 25160PAE7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and DEUTSCHE BK AG, you can compare the effects of market volatilities on Pfizer and 25160PAE7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 25160PAE7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 25160PAE7.
Diversification Opportunities for Pfizer and 25160PAE7
Poor diversification
The 3 months correlation between Pfizer and 25160PAE7 is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DEUTSCHE BK AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DEUTSCHE BK AG and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 25160PAE7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DEUTSCHE BK AG has no effect on the direction of Pfizer i.e., Pfizer and 25160PAE7 go up and down completely randomly.
Pair Corralation between Pfizer and 25160PAE7
Considering the 90-day investment horizon Pfizer Inc is expected to generate 2.18 times more return on investment than 25160PAE7. However, Pfizer is 2.18 times more volatile than DEUTSCHE BK AG. It trades about 0.06 of its potential returns per unit of risk. DEUTSCHE BK AG is currently generating about -0.13 per unit of risk. If you would invest 2,541 in Pfizer Inc on October 28, 2024 and sell it today you would earn a total of 68.00 from holding Pfizer Inc or generate 2.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 64.1% |
| Values | Daily Returns |
Pfizer Inc vs. DEUTSCHE BK AG
Performance |
| Timeline |
| Pfizer Inc |
| DEUTSCHE BK AG |
Pfizer and 25160PAE7 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 25160PAE7
The main advantage of trading using opposite Pfizer and 25160PAE7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 25160PAE7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 25160PAE7 will offset losses from the drop in 25160PAE7's long position.| Pfizer vs. Collegium Pharmaceutical | Pfizer vs. Phibro Animal Health | Pfizer vs. ANI Pharmaceuticals | Pfizer vs. Procaps Group SA |
| 25160PAE7 vs. Kuya Silver | 25160PAE7 vs. Freedom Holding Corp | 25160PAE7 vs. Hudson Acquisition I | 25160PAE7 vs. Vindicator Silver Lead Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |